Sector
PharmaceuticalsOpen
₹115.3Prev. Close
₹114.41Turnover(Lac.)
₹28.55Day's High
₹115.3Day's Low
₹112.9952 Week's High
₹176.5952 Week's Low
₹96.8Book Value
₹37.76Face Value
₹10Mkt Cap (₹ Cr.)
407.08P/E
49.22EPS
2.31Divi. Yield
015 Jul 2024
12:00 AM
AGM
Announcement Date: 15 Jul, 2024
31 Jan 2025
12:00 AM
EGM
14 May 2025
12:00 AM
Board Meeting
Agenda : Audited Result
Here are some of the stocks that may see significant price movement today: Reliance Industries, HCLTech, Sunteck Realty, etc.
| Y/e 31 Mar( In .Cr) | Mar-2024 | Mar-2023 | Mar-2022 | Mar-2021 |
|---|---|---|---|---|
Equity Capital | 42.16 | 48.13 | 28.69 | 28.69 |
Preference Capital | 1.08 | 1.08 | 0.78 | 0.71 |
Reserves | 57.17 | 28.3 | 15.75 | -24.28 |
Net Worth | 100.41 | 77.51 | 45.22 | 5.12 |
Minority Interest |
| Y/e 31 Mar( In .Cr) | Mar-2022 | Mar-2021 | Mar-2020 | Mar-2018 |
|---|---|---|---|---|
Revenue | 164.34 | 62.26 | 33.67 | 41.68 |
yoy growth (%) | 163.95 | 84.92 | -19.21 | -46.56 |
Raw materials | -30.86 | -23.52 | -15.48 | -21.53 |
As % of sales | 18.77 | 37.77 | 45.99 | 51.66 |
Employee costs | -16.21 | -13.02 | -10.57 | -10.89 |
| Y/e 31 Mar( In .Cr) | Mar-2022 | Mar-2021 | Mar-2020 | Mar-2018 |
|---|---|---|---|---|
Profit before tax | 64.9 | -16.96 | -24.24 | -12.69 |
Depreciation | -15.38 | -8.04 | -5.64 | -6.3 |
Tax paid | -20.33 | 3.93 | -1.19 | 0.38 |
Working capital | 29.28 | 5.11 | -23.18 | 16.67 |
Other operating items |
| Y/e 31 Mar | Mar-2022 | Mar-2021 | Mar-2020 | Mar-2018 |
|---|---|---|---|---|
Growth matrix (%) | ||||
Revenue growth | 163.95 | 84.92 | -19.21 | -46.56 |
Op profit growth | 575.87 | -742.93 | 333.98 | -102.37 |
EBIT growth | 887.98 | -262.21 | 7.28 | -127.49 |
Net profit growth | -375.97 | -72.81 | 390.71 | 5,718.25 |
| Particulars (Rupees in Crores.) | Mar-2025 | Mar-2024 | Mar-2023 | Mar-2022 | Mar-2021 |
|---|---|---|---|---|---|
Gross Sales | 138.5 | 111.19 | 93.07 | 194.08 | 86.25 |
Excise Duty | 0 | 0 | 0 | 0 | 0 |
Net Sales | 138.5 | 111.19 | 93.07 | 194.08 | 86.25 |
Other Operating Income | 0 | 0 | 0 | 0 | 0 |
Other Income | 2.23 | 1.45 | 3.4 | 2.09 | 1.56 |
Company Name | LTP (₹) | P/E (%) | Mkt.Cap (₹Cr.) | NP Qtr (₹Cr.) | Div.Yield (%) | Sales Qtr (₹.Cr) | Book Value (₹) |
|---|---|---|---|---|---|---|---|
Sun Pharmaceutical Industries Ltd SUNPHARMA | 1,677.5 | 94 | 4,02,584.41 | 2,000.46 | 0.95 | 7,107.14 | 101.44 |
Divis Laboratories Ltd DIVISLAB | 6,859.5 | 82.46 | 1,82,147.28 | 667 | 0.44 | 2,536 | 561.08 |
Cipla Ltd CIPLA | 1,497.6 | 25.13 | 1,20,934.05 | 1,485.4 | 1.07 | 4,254.47 | 397.41 |
Torrent Pharmaceuticals Ltd TORNTPHARM | 3,349.4 | 59.47 | 1,13,319.98 | 474 | 0.96 | 2,385 | 224.33 |
Dr Reddys Laboratories Ltd DRREDDY | 1,270.8 | 19.84 | 1,06,137.94 | 1,200.7 | 0.63 | 5,546.3 | 345.76 |
Figures of Market Capital(Mar Cap), Quarterly Net Profit(NP Qtr) and Quarterly Sales(Sales Qtr) are in ₹ Cr.
Managing Director & CEO
KUNAL NARENDRA GANDHI
Executive Director & CFO
Yogesh B Shah
Non-Exec. & Independent Dir.
Dhara P. Shah
Chairman & Independent Directo
Babulal Jain
Non Executive Director
Prashant Godha
Non Executive Director
Shashil Mendonsa
Company Sec. & Compli. Officer
Shekhar R Singh
Additional Director
Archana Yadav
4801/B & 4802/A,
GIDC Industrial Estate,
Gujarat - 393002
Tel: 91-02646-221422/220549
Website: http://www.lykalabs.com
Email: investorredressal@lykalabs.com; enquiry@lykalabs.c
C-101 247 Park,
L B S Marg, Vikhroli West,
Mumbai - 400083
Tel: 91-22-28515644/5606
Website: www.sharexindia.com
Email: support@sharexindia.com
Summary
Initially manufacturing formulations, Lyka Labs Limited brought bulk drugs into its operational fold by amalgamating Lyphin Chemicals Pvt Ltd with itself in Apr. 83. It also added a range of ayurvedic...
Read More
Reports by Lyka Labs Ltd
What is the Lyka Labs Ltd share price today?
What is the Market Cap of Lyka Labs Ltd?
What is the PE and PB ratio of Lyka Labs Ltd?
What is the 52 Week High and Low of Lyka Labs Ltd?
What is the CAGR of Lyka Labs Ltd?
What is the shareholding pattern of Lyka Labs Ltd?
IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000
IIFL Capital Services Support WhatsApp Number
+91 9892691696
Download The App Now
Follow us on
2025, IIFL Capital Services Ltd. All Rights Reserved
IIFL Capital Services Limited - Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248, DP SEBI Reg. No. IN-DP-185-2016
ARN NO : 47791 (AMFI Registered Mutual Fund Distributor)
This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.
